Clinical Trials Browser

Phase 1/2 × Cancer Cachexia × 90 days × Clear all

NCT07584057 2026-05-13

An Phase I/IIa Clinical Study to Evaluate the Safety/Tolerability, Pharmacokinetics and Preliminary Efficacy of INB301 Injection in Patients With Cancer Cachexia

Phase 1/2 Not yet recruiting

Cancer Cachexia